Date
As of August 21st, Pharmacare stopped LANTUS new start coverage and started funding BASAGLAR (biosimilar insulin glargine) for all new start type 1 diabetes patients and type 2 diabetes patients 17 years of age or older in the community.
For medication safety concerns and other detailed information, please view the formulary changes poster.
If you have any questions please contact:
Jessica Brednock or Gordon Harper, Medication Use Management Pharmacists Email: mumpharmacists@northernhealth.ca